Delisting riskPopularity #4,408
LSTA · NASDAQ · Biotechnology

Lisata Therapeutics (LSTA)

Develops certepetide for tumor-penetrating cancer therapy combinations.

$1.44
vs last close−0.04 (−3.04%)